Floatz logo

Oxcarbazepine

Epilepsy

University of PittsburghSmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
73/ 100

Competitive context

64 Active assets in the Epilepsy cohort.

Asset / SponsorPhaseRating
LAMOTRIGINE
Assiut University
Phase 4BBB
Eslicarbazepine Acetate
Bial - Portela C S.A.
Phase 4BBB
Topiramate
Université de Sherbrooke
Phase 4BBB
Carbamazepine
Assistance Publique - Hôpitaux de Paris
Phase 4BBB
Levetiracetam
Beijing Tiantan Hospital
Phase 4BBB

View all 50 →

Same molecule, other indications

Oxcarbazepine is also rated in:

focal epilepsyDormant
A
Indicative · Phase 4
80 / 100
View asset →
peripheral neuropathyDormant
BB
Indicative · Phase 4
68 / 100
View asset →
peripheral nervous system disorderDormant
BB
Indicative · Phase 4
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →